These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Isolation and characterization of antigens of Aspergillus fischeri. Hipp SS; Berns DS; Tompkins V Prep Biochem; 1971; 1(2):119-31. PubMed ID: 5005720 [No Abstract] [Full Text] [Related]
25. Isolation and characterization of alpha 1-acid glycoprotein from chimpanzee plasma. Li YT; Li SC J Biol Chem; 1970 Feb; 245(4):825-32. PubMed ID: 4984628 [No Abstract] [Full Text] [Related]
26. Studies on the conformational changes of plasminogen induced during activation to plasmin and by 6-aminohexanoic acid. Sjöholm I Eur J Biochem; 1973 Nov; 39(2):471-9. PubMed ID: 4272770 [No Abstract] [Full Text] [Related]
27. A METHOD FOR THE PREPARATION OF HUMAN PLASMINOGEN ON A LARGE SCALE. SHAMASH Y; RIMON A; MEGGED A; AVIRAM I Vox Sang; 1964; 9():191-201. PubMed ID: 14147437 [No Abstract] [Full Text] [Related]
28. Plasminogen-plasmin system. VI. Preparation of alpha 2-macroglobulin antiplasmin from human plasma. Iwamoto M; Abiko Y Biochim Biophys Acta; 1970 Sep; 214(3):402-10. PubMed ID: 4251763 [No Abstract] [Full Text] [Related]
29. Purification and characterization of anti-A agglutinin from Euhadra callizoma amaliae. Mukaida M; Takatsu A; Ishiyama I Vox Sang; 1974; 27(4):347-62. PubMed ID: 4370303 [No Abstract] [Full Text] [Related]
30. EQUINE ANTIHAPTEN ANTIBODY II. THE GAMMA-G(7S-GAMMA) COMPONENTS AND THEIR SPECIFIC INTERACTION. KLINMAN NR; ROCKEY JH; KARUSH F Immunochemistry; 1965 Mar; 47():51-60. PubMed ID: 14290269 [No Abstract] [Full Text] [Related]
31. Plasmic degradation of human fibrinogen. II. Further characterization of fragment D. Furlan M; Beck EA Biochim Biophys Acta; 1973 May; 310(1):205-16. PubMed ID: 4197006 [No Abstract] [Full Text] [Related]
32. [COMPARISON OF ANTIGENIC PROPERTIES OF CHROMALBUMIN AND NATIVE OVALBUMIN BY MEANS OF QUANTITATIVE PRECIPITATION]. KAVAI M; KESZTYUES L Kiserl Orvostud; 1964 Apr; 16():119-25. PubMed ID: 14155555 [No Abstract] [Full Text] [Related]
33. Purification and properties of frog skeletal muscle phosphorylase. Metzger BE; Glaser L; Helmreich E Biochemistry; 1968 Jun; 7(6):2021-36. PubMed ID: 4969099 [No Abstract] [Full Text] [Related]
34. Isolation and some properties of fibrinogen from human blood platelets. Ganguly P J Biol Chem; 1972 Mar; 247(6):1809-16. PubMed ID: 4258978 [No Abstract] [Full Text] [Related]
35. Isolation and properties of rat and rabbit growth hormones. Ellis S; Grindeland RE; Nuenke JM; Callahan PX Ann N Y Acad Sci; 1968 Feb; 148(2):328-42. PubMed ID: 4967796 [No Abstract] [Full Text] [Related]
36. Synthesis of secretory IgA in the rabbit. 3. Interaction of colostral IgA fragments with T chain. Lawton AR; Asofsky R; Mage RG J Immunol; 1970 Feb; 104(2):397-408. PubMed ID: 4189675 [No Abstract] [Full Text] [Related]
37. [Characterization of staphylococcal fibrinolysin by disc electrophoresis in connection with immunodiffusion]. Hentschel G; Blobel H Zentralbl Bakteriol Orig; 1968; 208(4):493-5. PubMed ID: 4255812 [No Abstract] [Full Text] [Related]
38. Different molecular forms of plasminogen and plasmin produced by urokinase in human plasma and their relation to protease inhibitors and lysis of fibrinogen and fibrin. Müllertz S Biochem J; 1974 Nov; 143(2):273-83. PubMed ID: 4282470 [TBL] [Abstract][Full Text] [Related]
39. Isolation and characterization of the clottable low molecular weight fibrinogen derived by limited plasmin hydrolysis of human fraction I-4. Sherman LA; Mosesson MW; Sherry S Biochemistry; 1969 Apr; 8(4):1515-23. PubMed ID: 4241001 [No Abstract] [Full Text] [Related]
40. Characterization of the terminal degradation products of canine fibrinogen by plasmin. Chen JP; Hutchison HT; Nanninga LB; Guest MM Biochim Biophys Acta; 1975 Mar; 386(1):69-79. PubMed ID: 123781 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]